Accretion Nutraveda Ltd (544694) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Accretion Nutraveda was incorporated on March 16, 2021 as ‘Accretion Nutraveda Private Limited’ which further converted on May 02, 2025 as ‘Accretion Nutraveda Limited’, a public limited company. It is in the business of the manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. It is a healthcare focused company specialising in contract manufacturing, serving domestic as well as export markets in various countries. It offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science.

Its product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support. It also manufactures Capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification, women’s health, and cognitive support. Its oral liquids include syrups, suspensions, and tonics, which are particularly suited for paediatric and geriatric segments. Additionally, it produces Traditional Ayurvedic Powders known as churans for digestive health, medicated ayurvedic oils for musculoskeletal and dermatological applications using traditional processes, and a range of external preparations like balms, ointments, creams, and gels for pain relief, skin care, and hair care.

Its leased manufacturing facility is designed for ayurvedic and nutraceutical production and is equipped with significant infrastructure that includes few Air Handling Units with HEPA filters, dedicated processing areas, and separate dispensing booths to prevent cross-contamination. The facility holds multiple certifications that attest to its adherence to quality and safety standards, including GMP certification for the manufacture of Ayurveda, Siddha & Unani Drugs from the Gujarat FDCA, WHO-GMP certification, FSSC 22000 for Food Safety Systems, ISO 9001:2015 for Quality Management Systems, ISO 45001:2018 for Occupational Health and Safety, as well as Halal certification and an FSSAI license.

Business area of the company

The company is engaged in manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, and Oral Powders, etc. It is a healthcare focused company specialising in contract manufacturing, serving domestic as well as export markets in various countries. It offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science.

Products of the company

• Tablets
• Capsules
• Oral Liquids
• Oral Powders / Churans (Oral Ayurvedic Powders)
• Oils
• External Preparations

Awards and recognitions

• 2024-25: The company was awarded the ISO 9001:2015 certification, recognizing its compliance with internationally accepted standards for quality management systems, ensuring consistency in products and services with a focus on customer satisfaction and continual improvement. 
• 2024-25: The company achieved the ISO 45001:2018 certification, demonstrating its adherence to globally recognized occupational health and safety management standards aimed at improving employee safety, reducing workplace risks, and creating a safe and healthy work environment.
• 2024-25: The company obtained the WHO-GMP (Good Manufacturing Practices) certification from Star Certifications UK, evidencing that its manufacturing facilities and processes comply with the guidelines prescribed by the World Health Organization for ensuring product quality, safety, and efficacy. 
• 2025-26: The company was awarded the Halal Certification from Star Certifications UK, confirming that its manufacturing processes, raw materials, and finished products conform to the requirements of the Halal Certification Scheme, thereby facilitating access to global markets that mandate Halal-compliant products.

History and milestones

• 2020-21: The company was incorporated as a Private Limited Company.
• 2021-22: The company entered into a lease deed for a period of 10 years.
• 2025-26: The company was converted from a Private Limited Company into a Public Limited Company.
• 2025-26: The company entered into a lease deed for a period of 10 years for the proposed manufacturing unit.